Unsuspected pulmonary embolism: Impact on mortality among cancer patients

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 5, 2012, Pages 406-409

  Piatek, Caroline ^a   O'Connell, Casey ^b  

^a LAC and USC Medical Center   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

cancer related thrombosis; incidental pulmonary embolism; pulmonary embolism; unsuspected pulmonary embolism

Indexed keywords

ANTIVITAMIN K; DALTEPARIN; HEPARIN;

ANTICOAGULATION; BLEEDING; CANCER PATIENT; CANCER SURVIVAL; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; FATIGUE; HUMAN; INCIDENCE; LUNG EMBOLISM; MORTALITY; OVERALL SURVIVAL; PULMONARY HYPERTENSION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SYMPTOM; UNSUSPECTED PULMONARY EMBOLISM; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; COMORBIDITY; HUMANS; INCIDENCE; NEOPLASMS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864883074     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328355392a     Document Type: Review

References (22)

1. Barrit DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960; 1:1309-1312.
2. Perrier A, Roy PM, Aujesky D, et al. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med 2004; 116:291-299. (Pubitemid 38230287)
3. Van Strijen MJ, de Monye W, Schiereck J, et al. Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients. Ann Intern Med 2003; 138:307-314. (Pubitemid 36205927)
4. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326:1240-1245.
5. Nijkeuter M, Sohne M, Tick LW, et al. The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study. Chest 2007; 131:517-523. (Pubitemid 46280414)
6. Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343:1846-1850. (Pubitemid 32104130)
7. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine 1999; 78:285-291. (Pubitemid 29439263)
8. Lee AYY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349:146-153. (Pubitemid 36818784)
9. bdel-Razeq HN, Mansour AH, Ismael YM. Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome-a comprehensive cancer center experience. Vasc Health Risk Manag 2011; 7:153-158.
10. Connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging MDCT scanning. J Thromb Haemost 2011; 9:305-311.
11. entali F, Ageno W, Pierfranceschi MG, et al. Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer. J Thromb Haemost 2011; 9:1081-1083.
12. Den Exter PL, Hooijer J, Dekkers OM, et al. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol 2011; 29:2405-2409.
13. Grigoropoulos NF, Shaw AS, Hampson FA, et al. Incidental pulmonary emboli in lymphoma patients are associated with aggressive disease and poor prognosis. J Thromb Haemost 2010; 8:2835-2836.
14. Sun JM, Kim TS, Lee J, et al. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy. Lung Cancer 2010; 69:330-336.
15. Franklin JM, Rahman N, Gleeson FV. The clinician's response to a report of an incidental pulmonary embolism detected on multidetector CT. Postgrad Med J 1033; 87:746-749.
16. 'Connell C, Razavi P, Liebman H. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. J Clin Oncol 2011; 29:4208-4209.
17. Carrier M, Righini M, Wells PS, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost 2010; 8:1716-1722.
18. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171:831-837.
19. DeMonaco NA, Dang Q, Kapoor WN, Ragni MV. Pulmonary embolism incidence is increasing with use of spiral computed tomography. Am J Med 2008; 121:611-617. (Pubitemid 351876184)
20. Donato AA, Khoche S, Santora J, Wagner B. Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res 2010; 126:e266-e270.
21. Eyer BA, Goodman LR, Washington L. Clinicians' response to radiologists' reports of isolated subsegmental pulmonary embolism or inconclusive interpretation of pulmonary embolism using MDCT. Am J Roentgenol 2005; 184:623-628. (Pubitemid 46657275)
22. Carrier M, Kimpton M, Le Gal G, et al. The management of a sub-segmental pulmonary embolism: a cross-sectional survey of Canadian thrombosis physicians. J Thromb Haemost 2011; 9:1412-1415.